| Projekat
|
Breast Cancer Research Foundation; Roche Diagnostics International; Fonds de la Recherche Scientifique (FNRS-CRD); ETOP IBCSG Partners Foundation (globally); Alliance for Clinical Trials in Oncology (North America); Breast International Group (BIG); National Clinical Trials Network of the National Cancer Institute; International Breast Cancer Study Group (IBCSG); Frontier Science and Technology Research Foundation; Southern Europe (Frontier Southern Europe); Rising Tide Foundation for Clinical Cancer Research [CCR-15-120, CCR-20-200, CCR-24-150]; Pink Ribbon Switzerland; Swiss Cancer League [KLS-3361-02]; San Salvatore Foundation; Swiss Group for Clinical Cancer Research; Clinical Cancer Research Foundation of Eastern Switzerland; Swiss Cancer Foundation, Switzerland; Piajoh Fondazione di Famiglia, Switzerland; Gruppo Giovani Pazienti "Anna dai Capelli Corti", Switzerland; Schweizer Frauenlauf Bernm, Switzerland; BIG Against Breast Cancer, Belgium; Baillet Latour Fund, Belgium; Gateway for Cancer Research, United States [G-15-1900]; Fondazione Umberto Veronesi, Italy; C A, Germany; Dutch Cancer Society, the Netherlands; Norwegian Breast Cancer Society, Norway; Pink Ribbon, Norway; ELGC K.K, Japan; Pink Ring, Japan; Korean Breast Cancer Foundation, South Korea; National Cancer Institute of the National Institutes of Health (NIH) [UG1CA189823, U24CA196171]; NIH [UG1CA189974, U10CA180888, U10CA180868]; NCORP [UG1CA189867]; National Cancer Institute of the NIH [CA180863]; Dutch Cancer Society, The Netherlands [KaWeFis Batch7/7723]; Canadian Cancer Society [707213]; Canada Foundation for Innovation; RETHINK Breast Cancer, Canada; Gilson Family Foundation, United States; [UG1CA189828] |
